1. EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neurofibromatosis type 1 patients

   • Ricardo Ribeiro
   • Ângelo Soares
   • Rui Medeiros

   LAB INVESTIGATION 20 September 2006 Pages: 225 - 229

2. Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells

   • Wei Zhang
   • Zhou Fei
   • Xiang Zhang

   Laboratory Investigation 20 September 2006 Pages: 231 - 240

   

3. PLXDC1 (TEM7) is identified in a genome-wide expression screen of glioblastoma endothelium

   • Robert M. Beaty
   • Jennifer B. Edwards
   • Gregory J. Riggins

   LABORATORY INVESTIGATION 20 September 2006 Pages: 241 - 248

   

4. Frequent loss of heterozygosity encompassing the hMLH1 locus in low grade astrocytic tumors

   • Tapasya Srivastava
   • Kunzang Chosdol
   • Subrata Sinha

   Original Paper 04 October 2006 Pages: 249 - 255

   

5. Images in neuro-oncology: rapid development of osseous and chondrous metaplasia in recurrent anaplastic ependymoma

   • Serguei Bannykh
   • Joachim M. Baehring

   Clinical–Patient Studies 13 October 2006 Pages: 257 - 258

   

6. Primary peripheral primitive neuroectodermal tumors of the spinal cord: report of two cases and review of the literature

   • R. Perry
   • I. Gonzales
   • S. Zacharoulis

   Clinical–Patient Studies 03 January 2007 Pages: 259 - 264

7. Feasibility and response to 1-(4-amino-2-methyl-5-pyrimidynyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride chemotherapy with pre-treated procarbazine for elderly patients with newly diagnosed glioblastoma

   • Mizuhiko Terasaki
   • Toshi Abe
   • Minoru Shigemori

   Clinical – Patient studies 26 August 2006 Pages: 265 - 269

8. A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme

   • Morris D. Groves
   • Vinay K. Puduvalli
   • W. K. Alfred Yung

   Clinical – Patient Studies 22 September 2006 Pages: 271 - 277

   

9. Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine

   • Anna Maria Mauro
   • Chiara Bomprezzi
   • Massimo Scerrati

   Clinical – Patient Studies 31 August 2006 Pages: 279 - 285

10. Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma

    • Antje Ernst-Stecken
    • Oliver Ganslandt
    • Gerhard Grabenbauer

    Clinical-Patient Studies 20 September 2006 Pages: 287 - 294

    

11. Prognostic factors for anaplastic astrocytomas

    • Alessia Compostella
    • Alicia Tosoni
    • Alba A. Brandes

    Clinical–Patient Studies 26 September 2006 Pages: 295 - 303

12. Assessment of verbal working memory before and after surgery for low-grade glioma

    • Pilar Teixidor
    • Peggy Gatignol
    • Hugues Duffau

    Clinical-Patient Studies 31 August 2006 Pages: 305 - 313

13. Clear cell Meningioma, an uncommon variant of meningioma: a clinicopathologic study of nine cases

    • D. Jain
    • M. C. Sharma
    • A. K. Mahapatra

    Clinical–Patient Studies 06 September 2006 Pages: 315 - 321

    

14. Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme

    • Giuseppe Luigi Banna
    • Daniela Bettio
    • Armando Santoro

    Letter to the Editor 23 September 2006 Pages: 323 - 325

15. Functional compensation of the claustrum: lessons from low-grade glioma surgery

    • Hugues Duffau
    • Emmanuel Mandonnet
    • Laurent Capelle

    Letter to the Editor 31 August 2006 Pages: 327 - 329